Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字H20223582

Company南京卡文迪许生物工程技术有限公司

Registration Date

August 10, 2022

Drug Information

Generic Name

利伐沙班片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

August 10, 2022

Company Information

Applicant Company

Company Name南京卡文迪许生物工程技术有限公司

Company Address

南京市栖霞区仙林街道仙林大学城纬地路9号

Manufacturing Company

Company Name江苏云阳集团药业有限公司

Company Address

江苏丹阳经济开发区顺康路18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy